IBSA Pharma Inc.
31 drugs in NADAC|0 Generic,31 Brand
IBSA Pharma Inc. lists 31 NDCs in the CMS NADAC file (0 generic, 31 brand), at an average NADAC of $5.35 per unit. The firm's full portfolio, pricing trend are listed below.
Total Drugs
31
0G / 31B
Avg Price / Unit
$5.3518
$4.47 – $24.71
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 31 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
levothyroxine sodium market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
l-Thyroxine therapeutic class
Review the broader class where IBSA Pharma Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does IBSA Pharma Inc. make?
IBSA Pharma Inc. lists 31 NDCs in the CMS NADAC file — 0 generic and 31 brand products.
What is the average price of IBSA Pharma Inc. drugs?
The average NADAC across IBSA Pharma Inc.'s portfolio is $5.3518 per unit, ranging from $4.4666 to $24.7113.
What types of drugs does IBSA Pharma Inc. make?
IBSA Pharma Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are l-Thyroxine (29), Nonsteroidal Anti-inflammatory Drug (2).
Has IBSA Pharma Inc. had any drug recalls?
No FDA enforcement recalls are matched to IBSA Pharma Inc. in the openFDA feed.